As of Dec 20, 2024, the Incyte stock's PE ratio is 404.94. This results from the current EPS of $0.17 and stock price of $68.84. The P/E ratio has an increase of 175% from the past four quarters average of 147.2.
The PE ratio of Incyte has averaged 240.37 over the last ten years. The current PE ratio of 404.94 is 68% above the historical average. In the past ten years, INCY's PE ratio was at its highest in the Dec 2015 quarter at 2,711.25, when the stock price was $108.45 and the EPS was $0.04. The lowest value was in the Sep 2022 quarter, when it reached 16.83 with a price of $66.64 and an EPS of $3.96.
Maximum annual increase: 207.56% in 2022
Maximum annual decrease: -93.28% in 2016
Year | PE ratio | Change |
---|---|---|
2023 | 23.52 | -55.2% |
2022 | 52.5 | 207.56% |
2021 | 17.07 | N/A |
2020 | N/A | N/A |
2019 | 41.98 | -65.67% |
2018 | 122.29 | N/A |
2017 | N/A | N/A |
2016 | 182.31 | -93.28% |
2015 | 2,711.25 | N/A |
2014 | N/A | N/A |
Currently, INCY's PE ratio is greater than its 3, 5 and 10-year historical averages.
INCY's PE ratio is higher than its peer stocks LLY and NVS. Incyte's current PE ratio of 404.94 is comparable to the average of its peer group, which is 41.07.
Stock name | PE ratio | Market cap |
---|---|---|
NVS Novartis AG | 11.25 | $194.15B |
AMGN Amgen Inc | 33.38 | $141.58B |
PFE Pfizer Inc | 34.68 | $149.38B |
LGND Ligand Pharmaceuticals Inc | 43.42 | $2.17B |
LLY ELI LILLY & Co | 82.64 | $728.85B |
INCY Incyte Corp | 404.94 | $13.26B |
ARDX Ardelyx Inc | N/A | $1.14B |
GERN Geron Corp | N/A | $2.11B |
INCY stock has a price to earnings ratio of 404.94 as of Dec 20, 2024.
As an average over the last 3 years, INCY stock has a PE ratio of 69.17.
As an average over the last 5 years, INCY stock has a PE ratio of 62.0.
Over the last ten years, the quarterly PE ratio reached a historic high of 2,711.25 in the Dec 2015 quarter.
INCY's price to earnings ratio is currently 68% above its 10-year historical average.
INCY's PE ratio is high because its earnings per share (EPS) is low relative to its stock price.
You can calculate the PE ratio by dividing the most recent stock price by the trailing twelve months EPS. As of today (Dec 20, 2024), Incyte's stock price is $68.84. The earnings per share for the trailing twelve months (TTM) ending Sep 2024 is $0.17. Therefore, Incyte's P/E ratio for today is 404.94. PE RATIO(404.94) = STOCK PRICE($68.84) / TTM EPS($0.17)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified. Data from and Sharadar.